PCV38 BOSENTAN IS A COST-EFFECTIVE TREATMENT FOR UNITED KINGDOM PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION OF WHO CLASS III
May 1, 2008, 00:00
10.1016/S1098-3015(10)70626-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)70626-4/fulltext
Title :
PCV38 BOSENTAN IS A COST-EFFECTIVE TREATMENT FOR UNITED KINGDOM PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION OF WHO CLASS III
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70626-4&doi=10.1016/S1098-3015(10)70626-4
First page :
Section Title :
Open access? :
No
Section Order :
356